Navigation Links
Hospira Reports Fourth-Quarter and Full-Year 2012 Results
Date:2/13/2013

as Net sales less Cost of products sold.(2)

Adjusted Net income is shown net of tax of $25.1 million, exclusive of the tax audit settlement, and $24.1 million for the three months ended 2012 and 2011, respectively, based on the statutory tax rates in the various tax jurisdictions in which the items occurred.(3)

The Non-GAAP financial measures contained in this press release (including adjusted gross profit, adjusted income from operations, adjusted net income and adjusted diluted Earnings Per Share) adjust for certain specified items. All Non-GAAP financial measures are intended to supplement the applicable GAAP measures and should not be considered in isolation from, or a replacement for, financial measures prepared in accordance with GAAP. Refer to Hospira's Form 8-K furnished on February 13, 2013.Hospira, Inc.Reconciliation of GAAP to Non-GAAP Financial Measures(Unaudited)(dollars in millions, except for per share amounts)Year ended December 31, 2012 Reconciliation of GAAP to Non-GAAP Financial Measures:Gross Profit(1)Income From

OperationsNet Income(2)Diluted EPSGAAP Financial Measures$
,113.4$
58.8$
44.2$
.27Specified Items:Facilities Optimization charges (A)—18.611.60.07Amortization of certain intangible assets (B)72.472.450.50.31Impairment of certain assets (C)—14.017.00.10Certain quality and product related charges (D)236.8236.8153.90.93Capacity expansion related charges (E)17.917.911.90.07Other restructuring charges (F)5.436.124.80.15Acquisition and integration related charges (G)—1.00.6—Effective settlement of IRS tax audit expense (H)——18.80.11Adj
'/>"/>

SOURCE Hospira, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine technology :

1. Hospira to Present at Upcoming Investor Conferences
2. Hospira and Q Core Medical Sign International Distribution Agreement for Sapphire Infusion System
3. Hospira to Present at the J.P. Morgan 31st Annual Healthcare Conference Jan. 8, 2013
4. Hospira Reports Third-Quarter 2012 Results
5. Hospira to Acquire Active Pharmaceutical Ingredient Manufacturing and R&D Facilities
6. Hospira Reports Second-Quarter 2012 Results
7. Hospira Expands Board of Directors With Election of Dennis M. Fenton
8. Hospira to Host Conference Call for Second-quarter 2012 Results
9. Hospira and Lancaster General Hospital Honored for Patient Safety Initiatives
10. I.V. Clinical Integration Helps Deliver Safety, Efficiency And Financial Benefits; Hospira Shares Snapshot Of Results, Process
11. Hospira to Present at Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/vzhr6h/video ) has ... Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - ... has been the topic of fascination since the era of ... and the Soviet Russia. Earlier even a small glimpse ...
(Date:1/23/2015)... BETHESDA, Md. , Jan. 23, 2015  Northwest Biotherapeutics, Inc. ... developing DCVax® personalized immune therapies for operable and inoperable solid ... will present at the 7 th Annual Phacilitate Immunotherapy ... NW Bio,s presentation at Phacilitate will take place on January ...
(Date:1/23/2015)... 23, 2015  Pete Rose, baseball,s all-time hits leader, is the ... reliever Myoflex, Ducere Pharma has announced. "Pete,s a ... to have him on board with Myoflex," said Ducere Pharma ... legendary player who is known across all generations. The passion ...
Breaking Medicine Technology:Video Telemedicine Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Video Telemedicine Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 2NW Bio To Present At The 7th Annual Phacilitate Immunotherapy Forum 3Pete Rose bets on Myoflex to relieve aches and pains 2
... 23 Anesiva, Inc. (Nasdaq: ANSV ) today announced that ... to join the Anesiva board of directors following completion of the ... is subject to a shareholder vote scheduled to take place at ... held on December 3, 2009 at 9:00 a.m. PST at 400 ...
... VIEJO, Calif., Nov. 23 Oceanside Pharmaceuticals, part of Valeant ... it has now launched chlordiazepoxide hydrochloride and clidinium bromide, an ... its first orders and expects to be a significant player ... has become an important division of our U.S. business with ...
Cached Medicine Technology:Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 3Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 4Oceanside Pharmaceuticals Announces Launch of Librax(R) AG 2
(Date:1/22/2015)... (PRWEB) January 22, 2015 Yesterday, ... Bonilla (D-Concord) and Kristin Olsen (R-Modesto) were honored ... leadership in advancing biotechnology, biomedical science, medical device ... Olsen each received the “2014 Life Sciences Champion” ...
(Date:1/22/2015)... Colorado (PRWEB) January 22, 2015 Four years since ... Queen – which coincided with the marriage of Avasa & Matthew ... THE ROAD, which is scheduled for release through White Swan Records ... message that there is a sacred path available to all of ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 As interest in ... health care gains momentum worldwide, Rev. Eric J. Hall ... Chaplaincy Network (HCCN), will be the keynote speaker on ... in Israel’s public health system. , The conference, “Hope and ...
(Date:1/22/2015)... 22, 2015 Lower-Auto-Insurance.com has released a new blog ... a car for reducing the costs of an auto insurance ... be able to get lower prices for their vehicle insurance policies. ... role in determining policy costs. Because of this, drivers should ...
(Date:12/26/2014)... 26, 2014 The US represents the largest ... In 2013, GlobalData’s forecast estimates that sales of branded therapies ... due to the high incidence of the disease, high drug ... Japan, and China. Increased sales of CRC therapies over the ...
Breaking Medicine News(10 mins):Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 3Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 4
... The Penn State College of Medicine,s Department of Public ... million over seven years to act as the data ... Institute,s AsthmaNet. This grant is one of the largest ... of multiple clinical centers across the nation that conducts ...
... skeletal muscles, it may be important to monitor heart ... are the findings from a study conducted by Nationwide ... Human Molecular Genetics . This is the first ... SMA. SMA is a debilitating neurological disease that ...
... HealthDay Reporter , TUESDAY, Aug. 10 (HealthDay News) -- After ... vertebroplasty was no better than a sham procedure in treating ... can, in fact, ease some patients, pain. In this ... into the affected part of the spine. For some ...
... TUESDAY, Aug. 10 (HealthDay News) -- Women,s cholesterol levels vary ... and fall, a new study reveals. This means that ... doctors may need to take readings over several months before ... the researchers noted. "Doctors who are looking at women ...
... near-weightless technology can measure the impact of a dangerous tackle ... and runway traffic, analyze a golf pro,s swing, orient the ... missiles on target. And as sensing devices improve, ... Teams of Tel Aviv University scientists are at the heart ...
... are used in hormone replacement therapies to counteract the ... the risk of uterine cancer. However, evidence in recent ... the risk of breast cancer. Now, University of Missouri ... hormone replacement therapies and found significantly different outcomes on ...
Cached Medicine News:Health News:College Of Medicine receives $54 million grant for asthma research 2Health News:Spinal muscular atrophy may also affect the heart 2Health News:Study Offers Support for Surgery After Compression Fracture 2Health News:Study Offers Support for Surgery After Compression Fracture 3Health News:Cholesterol Levels Fluctuate With Menstrual Cycle 2Health News:Cholesterol Levels Fluctuate With Menstrual Cycle 3Health News:Micromachines for a safer world 2Health News:Breast cancer risk varies among different progestins used in hormone replacement therapy 2
The DOT-approved A150 test is used for workplace testing, most publicly for federally mandated testing of transportation workers, but also in private company "drug free workplace" programs. Each hash...
... Our most popular onsite test! QuickScreen multi-panel ... urine sample, and your choice of any ... multi-panels offer total flexibility for your drug ... the specimen and the built-in timer tells ...
... Tests are available in 14 configurations including ... using Microgenics Antibody Technology, the SureStep™ MDMA ... care immunoassay targeted to detect MDMA that ... MDEA but no cross-reactivity to any isomer ...
... abuse tests are highly accurate in detecting the ... as confirmed by GC/MS testing. The assay provides ... method (such as GC/MS) must be used in ... should be applied to any drug of abuse ...
Medicine Products: